Clinical Trials in Los Angeles

Showing 1021-1040 of 16,901 trials

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

NCT04724369

This is a Phase 3 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for confirming or excluding the presence of neuroblastoma

Neuroblastoma

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)43 participantsStarted Nov 2021

Los Angeles, California, United States • San Francisco, California, United States • Indianapolis, Indiana, United States +5 more locations

RECRUITINGPhase 4< 1 mile

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

NCT06972056

This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerable than the others. Research participants will: * Be randomly assigned to one of the three medications. * Provide information about their migraine pattern using a daily headache diary and during research visits.

Migraine

Mayo Clinic1,335 participantsStarted Jul 2025

Flagstaff, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +20 more locations

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Find Trials by Condition in Los Angeles

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants

The Lilac Device Trial

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors